Research
Hormonal
AgRP neurons promote feeding and induce acute insulin resistance to prioritize glucose availability for the brain during hunger.
During periods of fasting or caloric restriction, the body biologically reduces insulin sensitivity in peripheral tissues to ensure the brain receives enough glucose. This is a survival mechanism driven by AgRP neurons, not a defect.
GoodSupportsHIGH confidence
Acute activation of AgRP neurons causes impaired systemic insulin sensitivity... This AgRP-neuron–dependent induction of peripheral insulin resistance results in reduced peripheral glucose deposition when food sources are limited.
Why this rating
Supported by optogenetic and chemogenetic studies in mice showing causal links between AgRP activation and insulin sensitivity.
Source
Arcuate Nucleus-Dependent Regulation of Metabolism—Pathways to Obesity and Diabetes Mellitus
Alexander Jaïs et al. · Endocrine Reviews · 2021
DOI 10.1210/endrev/bnab025
narrative_reviewCited 259×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Disruption of arcuate nucleus (ARC) neuronal regulation of energy balance and glucose homeostasis is a primary driver of obesity and type 2 diabetes mellitus.Good
- Leptin signaling in the arcuate nucleus is critical for regulating body weight, with its effects mediated primarily through AgRP and POMC neurons.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →